CTLA4 and neoplasm: Notably, ZVI-NP enhanced anti-tumor immunity via transforming pro-tumor M2 macrophages into anti-tumor M1, reducing Tregs and down-regulating CTLA-4 and PD-1 in CD8 + T cells to provoke their cytolytic activity against cancer cells.